"Omic" risk assessment.
Integration of data from different techniques is the key to effective validation of "hits" in large-scale screens. A discussion of validation methods for siRNA screens and protein-interaction screens reveals how to go beyond an arbitrary assignment of relevant to a more biologically meaningful identification of targets.